Priority 11 from the Kidney Transplant PSP
|Extra information provided by this PSP
|Original uncertainty examples
Does immunosuppression increase the risk of cardiovascular disease when compared to a GFR-matched cohort with CKD? Are their any anti-rejection drugs without side effects What side effects the medication has after transplant ? What do some patients get diarrhoea or recurrent infections on MMF? What changes have there been in anti-rejection drugs in past 20 years and have the side effects improved? How will immunosuppression impact on my life after my transplant? Why aren't patients given more advice on serious life threatening side effects of immuno suppression drugs? What drugs will I need to take after a having a kidney transplant or becoming a living donor and what effects can these drugs have? Please can an answer be found to deal with bowel upset that seems to be unavoidable with mycophenolate? How the side effects of anti-rejection drugs can be lessened e.g. muscle cramps Side effects of anti rejection drugs Do we need MMF/MPA in long term imunosupresion?
Patients x 8 Carers x 1 Clinicians x 3
|Outcomes to be measured
|Drug side effects, adverse events
|PSP unique ID
|Total number of uncertainties identified by this PSP.
|90 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
|Date of priority setting workshop
|3 February 2016